Home/Filings/4/0001415889-25-018751
4//SEC Filing

Anderson Cynthia Lynn 4

Accession 0001415889-25-018751

CIK 0001411685other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:49 PM ET

Size

5.1 KB

Accession

0001415889-25-018751

Insider Transaction Report

Form 4
Period: 2025-06-30
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    2025-06-30$1.70/sh+6,617$11,24912,801 total
Footnotes (1)
  • [F1]The Reporting Person is voluntarily reporting the acquisition of shares under the Issuer's 2019 Employee Stock Purchase Plan, as amended, in a transaction exempt under Rule 16b-3(c) and Rule 16b-3(d).

Issuer

Vistagen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001989905

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:49 PM ET
Size
5.1 KB